Bringing together manufacturers, regulators and payers to discuss developments impacting market entry, pricing and patient outcomes

Join the conversation about a changing pharma landscape at the Pathways to Access & Reimbursement Forum on June 16-17, 2020 in Toronto.

Top Reasons to Attend:

  • Get direction on the latest changes to drug reviews and pricing ceilings to better inform market access and pricing strategies
  • Gain insights on reimbursement regimes though Q & A with public and private payers
  • Walk away with an understanding of how to bring innovative solutions to market
  • Hear how other jurisdictions are approaching HTA and pricing negotiations
  • Learn about developments in precision medicine that could increase the safety and efficacy of treatments while reducing healthcare spending

Stay tuned for more details about our 2020 program.

Past Attending Organizations Include:
  • Sidley & Austin LLP
  • Paladin Labs Inc
  • Boehringer Ingelheim Canada Ltd
  • Clinical Trials Ontario
  • Sun Life Financial
  • Green Shield Canada
  • PIVINA Consulting Inc
  • LifeLabs
  • Amgen Canada Inc
  • Pan-Canadian Pharmaceutical Alliance
  • Canopy Growth Corporation
  • Otsuka Canada Pharmaceutical Inc
  • Norton Rose Fulbright Canada LLP
  • GSK
  • Cancer Care Ontario
  • Bristol Myers Squibb
  • Cornerstone Research Group
  • Novartis Canada
  • Sandoz Canada Inc
  • Innovative Medicines Canada
  • Ipsen Biopharmaceuticals Canada
  • Equitable Life of Canada
  • SteriMax
  • Brougham Consulting Inc
  • Osler Hoskin & Harcourt LLP
  • Canadian Organization for Rare Disorders
  • Leslie Dan Faculty of Pharmacy
  • GlaxoSmithKline Plc
  • RWW Consultants
  • AstraZeneca Canada Inc
  • Innomar Strategies Inc
  • AbbVie Corporation
  • Great West Life
  • Jamp Pharma Corporation

Register early to secure the best rate!

Looking for the 2019 edition of the Pathways to Access & Reimbursement conference?

Click here for more information.